Admission into the BII Venture Lab Program

Mar 1, 2024

Glaze Life Sciences joins the BioInnovation Institute Venture Lab Program!

Glaze Life Sciences is happy to share that we have been accepted into the Venture Lab Program at the BioInnovation Institute (BII), Copenhagen, Denmark.

BII is an international enterprise foundation funded by the generous Novo Nordisk Foundation. Their aim is to foster the development and help accelerate innovative life science startups.

Their Venture Lab program is their acceleration program specifically designed to help accelerate early-stage start-ups and Glaze Life Sciences is part of their sixth cohort. Our mission to revolutionize diabetes care perfectly aligns with BII's mission to create innovative solutions for the health tech sector.

Glaze Life Sciences is excited to take up BII’s offerings in terms of infrastructure, funding and networking to help succeed in our mission to revolutionize diabetes care.

Watch the YouTube below to learn more about Glaze Life Sciences and the other companies in the cohort.

Photo Credit for the BII building: Esben Zøllner Olesen // BioInnovation Institute. 

© Glaze Life Sciences. 2023. All rights reserved.